tianfoshen

for treatment of colorectal cancer, composed of Radix Panacis Quinquefolii, Venenum Bufonis, Radix Asparagi, Bulbus Iphigenia Indica, Radix Acanthopanax obouatus, Radix Actinidia chinensis Planch, Fructus Hippophae, and Fructus Citri Sarcodactylis

Also Known As:

Networked: 3 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cao, Bangwei: 1 article (01/2019)
2.	Che, Juanjuan: 1 article (01/2019)
3.	Li, Huihui: 1 article (01/2019)
4.	Ma, Nina: 1 article (01/2019)
5.	Wang, Jing: 1 article (01/2019)
6.	Zhao, Lei: 1 article (01/2019)
7.	Lu, Yin: 1 article (02/2017)
8.	Wang, Hengbin: 1 article (02/2017)
9.	Wang, Siliang: 1 article (02/2017)
10.	Chen, G W: 1 article (06/2001)

Related Diseases

1.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/01/2019 - "Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy." 02/28/2017 - "In this study, therefore, we determined whether Tianfoshen oral liquid, a Chinese traditional medicine that has been used to treat non-small cell lung cancer, would be therapeutically beneficial for colorectal cancer patients. " 01/01/2019 - "As an important Chinese herb injection, Tianfoshen (TFS) oral liquid is widely used in Chinese non-small cell lung cancer (NSCLC) patients. "
2.	Colorectal Neoplasms (Colorectal Cancer) 02/28/2017 - "In addition, we demonstrated that Tianfoshen oral liquid suppressed multiple relevant key players that sustain and promote colorectal cancer, which is suggests the potential therapeutic efficacy of Tianfoshen oral liquid in future colorectal cancer treatments." 02/28/2017 - "We identified 276 major candidate targets for Tianfoshen oral liquid that are central to colorectal cancer progression. " 02/28/2017 - "We further employed a comprehensive strategy that included chemoinformatics, bioinformatics and network biology methods to unravel novel insights into the active compounds of Tianfoshen oral liquid and to identify the common therapeutic targets and processes for colorectal cancer treatment. " 02/28/2017 - "Our data show that Tianfoshen oral liquid effectively inhibits growth of colorectal cancer cells both in vitro and in vivo. " 02/28/2017 - "In this study, therefore, we determined whether Tianfoshen oral liquid, a Chinese traditional medicine that has been used to treat non-small cell lung cancer, would be therapeutically beneficial for colorectal cancer patients. "
3.	Neoplasms (Cancer) 06/01/2001 - "[Clinical and experimental study on treatment of moderate and advanced malignant tumors with tianfoshen oral liquid]." 06/01/2001 - "To investigate the clinical efficacy of Tianfoshen oral liquid (TFS) in treating moderate and advanced malignant tumors and its mechanism. "
4.	Carcinogenesis 02/28/2017 - "Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis."
5.	Yin Deficiency (Yinxu) 01/01/2019 - "To evaluate the efficacy and safety of Tianfoshen (TFS) oral liquid plus chemotherapy in Chinese NSCLC patients with Qi and Yin deficiency syndrome, an observational study was conducted in Beijing Friendship Hospital between August 2012 and July 2016. "

Related Drugs and Biologics

1.	tianfoshen

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)
2.	Therapeutics
3.	Drug Therapy (Chemotherapy)